📚 其他文獻
Association between pre-operative long-term aspirin use and post-operative outcomes following extracranial-intracranial bypass for moyamoya disease: National Inpatient Sample analysis.
OBJECTIVE: Moyamoya disease (MMD) carries significant morbidity. While management focuses on treatme
Superficial temporal artery dilation and the risk of transient neurological events after revascularization for moyamoya disease: Impact of preoperative PCA stenosis.
OBJECTIVE: The superficial temporal artery (STA)-to-middle cerebral artery (MCA) anastomosis is an e
Acetazolamide-challenged ASL shows comparable performance to CT perfusion for angiographic outcomes in moyamoya angiopathy.
BACKGROUND: Moyamoya angiopathy is a chronic steno-occlusive cerebrovascular disorder in which asses
Impaired cerebral autoregulation in patients with moyamoya disease and moyamoya syndrome: A prospective cross-sectional study.
Moyamoya disease and syndrome (MMDS) are rare cerebrovascular etiologies defined by stenosis of the
Comorbidities in sickle cell disease by age in the Indiana sickle cell data collection (IN-SCDC).
OBJECTIVE: Survival for individuals with sickle cell disease (SCD) is increasing, and along with it
The integrity of the Circle of Willis predicted hemodynamic changes after bypass surgery in Moyamoya disease: a prospective cohort study by 4D flow MRI.
OBJECTIVES: The anatomical completeness of the Circle of Willis (CoW) plays an important role in col
Contrasting Cerebral Hyperperfusion Patterns in Moyamoya Disease Versus Atherosclerotic Occlusive Cerebrovascular Disease: Insights From Day-One 99m Tc-ECD SPECT After Revascularization.
Extracranial-to-intracranial conversion: postoperative vascular remodeling in moyamoya disease after revascularization.
OBJECTIVE: Effective revascularization in moyamoya disease (MMD) entails not only the formation of e